Copyright Reports & Markets. All rights reserved.

Global Biosimilars/follow-on-biologics Market Status, Trends and COVID-19 Impact Report

Buy now

Table of Contents

    Section 1 Biosimilars/follow-on-biologics Market Overview

    • 1.1 Biosimilars/follow-on-biologics Market Scope
    • 1.2 COVID-19 Impact on Biosimilars/follow-on-biologics Market
    • 1.3 Global Biosimilars/follow-on-biologics Market Status and Forecast Overview
      • 1.3.1 Global Biosimilars/follow-on-biologics Market Status 2016-2021
      • 1.3.2 Global Biosimilars/follow-on-biologics Market Forecast 2022-2027

    Section 2 Global Biosimilars/follow-on-biologics Market Manufacturer Share

    • 2.1 Global Manufacturer Biosimilars/follow-on-biologics Sales Volume
    • 2.2 Global Manufacturer Biosimilars/follow-on-biologics Business Revenue

    Section 3 Manufacturer Biosimilars/follow-on-biologics Business Introduction

    • 3.1 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Introduction
      • 3.1.1 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales Volume, Price, Revenue and

    Gross margin 2016-2021

    • 3.1.2 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Distribution by Region
    • 3.1.3 Novartis (Sandoz) Interview Record
    • 3.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Business Profile
    • 3.1.5 Novartis (Sandoz) Biosimilars/follow-on-biologics Product Specification
  • 3.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Business Introduction
    • 3.2.1 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales Volume, Price,
  • Revenue and Gross margin 2016-2021

    • 3.2.2 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Business Distribution by

    Region

    • 3.2.3 Interview Record
    • 3.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Business Overview
    • 3.2.5 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Specification
  • 3.3 Manufacturer three Biosimilars/follow-on-biologics Business Introduction
    • 3.3.1 Manufacturer three Biosimilars/follow-on-biologics Sales Volume, Price, Revenue and
  • Gross margin 2016-2021

    • 3.3.2 Manufacturer three Biosimilars/follow-on-biologics Business Distribution by Region
    • 3.3.3 Interview Record
    • 3.3.4 Manufacturer three Biosimilars/follow-on-biologics Business Overview
    • 3.3.5 Manufacturer three Biosimilars/follow-on-biologics Product Specification

      Section 4 Global Biosimilars/follow-on-biologics Market Segmentation (By Region)

      • 4.1 North America Country
        • 4.1.1 United States Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-

      2021

      • 4.1.2 Canada Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.1.3 Mexico Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
    • 4.2 South America Country
      • 4.2.1 Brazil Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.2.2 Argentina Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
    • 4.3 Asia Pacific
      • 4.3.1 China Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.3.2 Japan Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.3.3 India Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.3.4 Korea Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.3.5 Southeast Asia Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-
    • 2021

      • 4.4 Europe Country
        • 4.4.1 Germany Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
        • 4.4.2 UK Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
        • 4.4.3 France Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
        • 4.4.4 Spain Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
        • 4.4.5 Italy Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
      • 4.5 Middle East and Africa
        • 4.5.1 Africa Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-2021
        • 4.5.2 Middle East Biosimilars/follow-on-biologics Market Size and Price Analysis 2016-

      2021

      • 4.6 Global Biosimilars/follow-on-biologics Market Segmentation (By Region) Analysis

      2016-2021

      • 4.7 Global Biosimilars/follow-on-biologics Market Segmentation (By Region) Analysis

      Section 5 Global Biosimilars/follow-on-biologics Market Segmentation (by Product Type)

      • 5.1 Product Introduction by Type
        • 5.1.1 Human growth hormone Product Introduction
        • 5.1.2 Erythropoietin Product Introduction
        • 5.1.3 Monoclonal antibodies Product Introduction
        • 5.1.4 Insulin Product Introduction
        • 5.1.5 Interferon/Granulocyte-Colony Stimulating Factor Product Introduction
      • 5.2 Global Biosimilars/follow-on-biologics Sales Volume by Erythropoietin016-2021
      • 5.3 Global Biosimilars/follow-on-biologics Market Size by Erythropoietin016-2021
      • 5.4 Different Biosimilars/follow-on-biologics Product Type Price 2016-2021
      • 5.5 Global Biosimilars/follow-on-biologics Market Segmentation (By Type) Analysis

      Section 6 Global Biosimilars/follow-on-biologics Market Segmentation (by Application)

      • 6.1 Global Biosimilars/follow-on-biologics Sales Volume by Application 2016-2021
      • 6.2 Global Biosimilars/follow-on-biologics Market Size by Application 2016-2021
      • 6.2 Biosimilars/follow-on-biologics Price in Different Application Field 2016-2021
      • 6.3 Global Biosimilars/follow-on-biologics Market Segmentation (By Application) Analysis

      Section 7 Global Biosimilars/follow-on-biologics Market Segmentation (by Channel)

      • 7.1 Global Biosimilars/follow-on-biologics Market Segmentation (By Channel) Sales Volume

      and Share 2016-2021

      • 7.2 Global Biosimilars/follow-on-biologics Market Segmentation (By Channel) Analysis

      Section 8 Biosimilars/follow-on-biologics Market Forecast 2022-2027

      • 8.1 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Region)
      • 8.2 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Type)
      • 8.3 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By

      Application)

      • 8.4 Biosimilars/follow-on-biologics Segmentation Market Forecast 2022-2027 (By Channel)
      • 8.5 Global Biosimilars/follow-on-biologics Price Forecast

      Section 9 Biosimilars/follow-on-biologics Application and Client Analysis

      • 9.1 Blood disorders Customers
      • 9.2 Oncology diseases Customers
      • 9.3 Chronic and autoimmune diseases Customers
      • 9.4 Growth hormone deficiencies Customers

      Section 10 Biosimilars/follow-on-biologics Manufacturing Cost of Analysis

        11.0 Raw Material Cost Analysis

          11.0 Labor Cost Analysis

            11.0 Cost Overview

              Section 11 Conclusion

                Section 12 Methodology and Data Source

                  Chart and Figure

                    Figure Biosimilars/follow-on-biologics Product Picture

                      Chart Global Biosimilars/follow-on-biologics Market Size (with or without the impact of

                        COVID-19)

                          Chart Global Biosimilars/follow-on-biologics Sales Volume (Units) and Growth Rate 2016-

                            2021

                              Chart Global Biosimilars/follow-on-biologics Market Size (Million $) and Growth Rate 2016-

                                2021

                                Global Biosimilars/follow-on-biologics Market Status, Trends and COVID-19 Impact Report
                                2022
                                Single User License Report: 2350 USD
                                Corporate User License Report: 4700 USD
                                Section Price: As below
                                Page: 115
                                Chart and Figure: 142
                                Publisher: BisReport
                                Delivery Time: 48 hour



                                In the past few years, the Biosimilars/follow-on-biologics market experienced a huge
                                change under the influence of COVID-19, the global market size of Biosimilars/follow-on-
                                biologics reached xx million $ in 2021 from xx in 2016 with a CAGR of xx from 2016-2021 is.
                                As of now, the global COVID-19 Coronavirus Cases have exceeded 500 million, and the
                                global epidemic has been basically under control, therefore, the World Bank has estimated
                                the global economic growth in 2021 and 2022. The World Bank predicts that the global
                                economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022.
                                According to our research on Biosimilars/follow-on-biologics market and global economic
                                environment, we forecast that the global market size of Biosimilars/follow-on-biologics will
                                reach xx million $ in 2027 with a CAGR of % from 2022-2027.

                                Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
                                by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
                                recover and partially adapted to pandemic restrictions. The research and development of
                                vaccines has made breakthrough progress, and many governments have also issued various
                                policies to stimulate economic recovery, particularly in the United States, is likely to provide
                                a strong boost to economic activity but prospects for sustainable growth vary widely
                                between countries and sectors. Although the global economy is recovering from the great
                                depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
                                period. The pandemic has exacerbated the risks associated with the decade-long wave of
                                global debt accumulation. It is also likely to steepen the long-expected slowdown in
                                potential growth over the next decade.

                                The world has entered the COVID-19 epidemic recovery period. In this complex economic
                                environment, we published the Global Biosimilars/follow-on-biologics Market Status,
                                Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the
                                global Biosimilars/follow-on-biologics market , This Report covers the manufacturer data,
                                including: sales volume, price, revenue, gross margin, business distribution etc., these data
                                help the consumer know about the competitors better. This report also covers all the
                                regions and countries of the world, which shows the regional development status, including
                                market size, volume and value, as well as price data. Besides, the report also covers segment
                                data, including: type wise, industry wise, channel wise etc. all the data period is from 2016-
                                2021, this report also provide forecast data from 2022-2027.

                                Section 1: 100 USD——Market Overview

                                Section (2 3): 1200 USD——Manufacturer Detail
                                Novartis (Sandoz)
                                Synthon Pharmaceuticals
                                Teva Pharmaceutical Industries
                                LG Life Sciences
                                Celltrion Biocon
                                Hospira
                                Merck Serono (Merck)
                                Biogen idec
                                Genentech (Roche)

                                Section 4: 900 USD——Region Segmentation
                                North America (United States, Canada, Mexico)
                                South America (Brazil, Argentina, Other)
                                Asia Pacific (China, Japan, India, Korea, Southeast Asia)
                                Europe (Germany, UK, France, Spain, Italy)
                                Middle East and Africa (Middle East, Africa)

                                Section (5 6 7): 700 USD——
                                Product Type Segmentation
                                Human growth hormone
                                Erythropoietin
                                Monoclonal antibodies
                                Insulin
                                Interferon/Granulocyte-Colony Stimulating Factor

                                Application Segmentation
                                Blood disorders
                                Oncology diseases
                                Chronic and autoimmune diseases
                                Growth hormone deficiencies

                                Channel (Direct Sales, Distribution Channel) Segmentation

                                Section 8: 500 USD——Market Forecast (2022-2027)

                                Section 9: 600 USD——Downstream Customers

                                Section 10: 200 USD——Raw Material and Manufacturing Cost

                                Section 11: 500 USD——Conclusion

                                Section 12: Research Method and Data Source

                                Buy now